CARS1 and neoplasm: In our work, the peptide-based CARs were produced and optimized, and their functionalities (cytotoxicity, tumor growth inhibition, etc) were verified in vitro and in vivo. Peptide-based A1-CARs recognizing A549 cells showed ligand specific cytotoxicity, which were efficacious in mouse xenograft model.